Archives: Downloads
Prevalence of Neurocognitive Impairment in Patients with Rheumatoid Arthritis – A Systematic Review and Meta-analysis
Learning Objectives:
1. Describe the prevalence of neurocognitive impairment in patients with rheumatoid arthritis.
2. Understand the factors that moderate the prevalence of neurocognitive impairment in patients with rheumatoid arthritis.
Pankowski, D., Wytrychiewicz-Pankowska, K., Pisula, E., & Fal, A. M. (2024). Prevalence of neurocognitive impairment in patients with rheumatoid arthritis – a systematic review and meta-analysis. The Clinical Neuropsychologist, 1–21. https://doi.org/10.1080/13854046.2024.2378521
Influence of Social Determinants of Health and Adversity on Computerized Neurocognitive Assessment
Learning Objectives:
1. Describe how adversity affects cognition and performance on baseline neurocognitive assessment among athletes.
2. Understand how social determinants of health may attenuate individual demographic factors, including race, on computerized neurocognitive testing.
Lemke, J., D’Alessio, A. S., Briggs, F. B. S., & Bailey, C. (2024). Influence of social determinants of health and adversity on computerized neurocognitive assessment. The Clinical Neuropsychologist, 1–20. https://doi.org/10.1080/13854046.2024.2375801
Diagnosis Coding of Neurocognitive Disorders
Learning Objectives:
1. Understand the structure of the ICD-10-CM and the rules and conventions of diagnosis coding, as relevant to neurocognitive disorders.
2. Learn to use the ICD-10-CM directly and accurately to code neurocognitive disorders, neurocognitive signs and symptoms, and etiologies underlying neurocognitive disorders.
Uysal, S. (2024). Diagnosis coding of neurocognitive disorders. The Clinical Neuropsychologist, 1–16. https://doi.org/10.1080/13854046.2024.2345925
Neuropsychological assessment, intervention, and best practices for women with non-central nervous system cancer: A scoping review of current standards
Learning Objectives:
1. Understand how women’s cognitive ability may be differentially impacted by cancer and its treatment and understand unique psychosocial stressors for women with breast and gynecological cancers.
2. Appreciate the best approach when clinicians are assessing women who are undergoing or have undergone cancer treatment for non-central nervous system cancer, including the status of available research.
VanLandingham, H. B., Ellison, R. L., Turchmanovych-Hienkel, N., Alfonso, D., Oh, A., Kaseda, E. T., … Khan, H. (2024). Neuropsychological assessment, intervention, and best practices for women with non-Central nervous system cancer: A scoping review of current standards. The Clinical Neuropsychologist, 1–32. https://doi.org/10.1080/13854046.2024.2343147